Skip to main content
Stoke Therapeutics, Inc. logo

Stoke Therapeutics, Inc. — Investor Relations & Filings

Ticker · STOK ISIN · US86150R1077 LEI · 549300RD25SS2DIJHJ67 US Manufacturing
Open in API
Filings indexed 558 across all filing types
Latest filing 2020-07-16 Regulatory Filings
Country US United States of America
Listing US STOK

About Stoke Therapeutics, Inc.

https://www.stoketherapeutics.com/

Stoke Therapeutics, Inc. is a biotechnology company focused on developing treatments for severe genetic diseases by addressing their underlying cause. The company utilizes its proprietary research platform, TANGO (Targeted Augmentation of Nuclear Gene Output), an RNA-based approach designed to restore protein levels. This technology works by upregulating protein expression from the healthy copy of a gene to compensate for a mutated or non-functioning copy, a mechanism particularly suited for haploinsufficient diseases. Stoke's lead investigational medicine, zorevunersen (STK-001), is in late-stage clinical development for the treatment of Dravet syndrome, a severe and progressive genetic epilepsy. The company is also advancing its platform to treat other genetic conditions, including autosomal dominant optic atrophy (ADOA).

Recent filings

Filing Released Lang Actions
Regulatory Filings 2020
Regulatory Filings Classification · 95% confidence The document is a letter from Stoke Therapeutics, Inc. to the SEC requesting acceleration of effectiveness for a Registration Statement on Form S-3. It is a correspondence related to a regulatory filing process, specifically about a registration statement for securities. The document is short (1551 characters) and does not contain financial data, report content, or detailed disclosures. It is not a report itself but an administrative request related to a filing. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2020-07-16 English
Regulatory Filings 2020
Regulatory Filings Classification · 80% confidence The provided document text appears to be encoded or encrypted and does not contain any readable content, keywords, regulatory headers, form names, fiscal period dates, or document titles that can be used to identify the filing type. The text is approximately 15,000 characters long, which is substantial, but without any meaningful content or context, it is impossible to classify it as a specific report or announcement. Given the lack of identifiable information and the fallback rule for documents that do not fit any specific category, the appropriate classification is Regulatory Filings (RNS).
2020-07-16 English
S-3
Capital/Financing Update Classification · 100% confidence The document is a Form S-3 Registration Statement filed with the SEC, which is used by companies to register securities for public offering. It includes detailed information about the types of securities to be offered (common stock, preferred stock, debt securities, warrants, subscription rights, and units) and the maximum aggregate offering price. The document is a registration statement under the Securities Act of 1933, not a financial report, earnings release, or management discussion. It is a capital markets filing related to fundraising and securities issuance. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it contains the full registration statement text, not just an announcement or a brief notice, confirming it is a primary filing of this type.
2020-07-10 English
FORM 4 SUBMISSION
Director's Dealing
2020-07-09 English
FORM 4 SUBMISSION
Director's Dealing
2020-07-09 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The text includes a press release about the publication of scientific data related to the company's proprietary technology, but it does not contain financial statements or detailed financial analysis. It also explicitly states that the press release is attached as an exhibit and is being furnished, not filed, indicating this is an announcement rather than a full report. The document is not an earnings release, annual report, or interim report, nor does it fit into categories like management changes or legal proceedings. Given the nature of the filing and the content, this is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous SEC filings that do not fit other specific categories.
2020-07-09 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.